Skip to content
About Us
ABOUT US
APPROACH
CAREERS
LICENSING
CONTACT US
Focus Areas
OBESITY
INFLAMMATION
CANCER
Pipeline
ALL ASSETS
INHBE siRNA
IL-13 x TSLP
TMPRSS6
MYOSTATIN (GDF8)
Updates
ALL UPDATES
PRESS RELEASES
VIDEOS
Investors
INVESTOR OVERVIEW
PRESS RELEASES
EVENTS & PRESENTATIONS
STOCK INFORMATION
FINANCIALS & FILINGS
Press Releases
Updates
Search
Search
All Resources
Press Releases
Videos
All Resources
Press Releases
Videos
Press Releases
The Next Chapter in Obesity Therapeutics: Vial’s INHBE siRNA Draws KOL Praise as a Next‑Generation Obesity Therapy
Read Article
Press Releases
Vial Initiates Phase 1 Trial of VIAL-INHBE, an INHBE (Activin E) siRNA for the Treatment of Obesity
Read Article
Press Releases
The Next Chapter in Obesity Therapeutics: Vial’s INHBE siRNA Draws KOL Praise as a Next‑Generation Obesity Therapy
Read Article
Press Releases
Vial Initiates Phase 1 Trial of VIAL-INHBE, an INHBE (Activin E) siRNA for the Treatment of Obesity
Read Article
Contact
Information
E:
contact@vial.com
S:
Linkedin
,
X
Join our mail list
"
*
" indicates required fields
Your email
*
Send
Δ
Get in touch!
Compose the future with us
"
*
" indicates required fields
Comments
This field is for validation purposes and should be left unchanged.
Name
*
Email
*
Comment
Δ
Clear search querie